Mayne Pharma Group Limited (ASX:MYX)
Australia flag Australia · Delayed Price · Currency is AUD
5.02
+0.12 (2.45%)
Jun 6, 2025, 4:10 PM AEST

Revenue by Product

Fiscal year is July - June.
Year Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 NaN - NaN
Dermatology
174.86M
Log In
Log In
Log In
Log In
Upgrade
Dermatology Growth
206.81%
Log In
Log In
Log In
Log In
Upgrade
Womens Health
142.83M
Log In
Log In
Log In
Log In
Upgrade
Womens Health Growth
130.78%
Log In
Log In
Log In
Log In
Upgrade
International
70.71M
Log In
Log In
Log In
Log In
Upgrade
International Growth
9.29%
Log In
Log In
Log In
Log In
Upgrade
Metrics Contract Services
-
Log In
Log In
Log In
Log In
Upgrade
Metrics Contract Services Growth
-
Log In
Log In
Log In
Log In
Upgrade
Generic Products
-
Log In
Log In
Log In
Log In
Upgrade
Generic Products Growth
-
Log In
Log In
Log In
Log In
Upgrade
Specialty Products
-
Log In
Log In
Log In
Log In
Upgrade
Specialty Products Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is July - June.
Year Ending
Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 NaN - NaN
United States
322.13M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
158.81%
Log In
Log In
Log In
Log In
Upgrade
Australia and New Zealand
40.34M
Log In
Log In
Log In
Log In
Upgrade
Australia and New Zealand Growth
-2.09%
Log In
Log In
Log In
Log In
Upgrade
Canada
13.37M
Log In
Log In
Log In
Log In
Upgrade
Canada Growth
34.62%
Log In
Log In
Log In
Log In
Upgrade
Europe and Other
7.13M
Log In
Log In
Log In
Log In
Upgrade
Europe and Other Growth
98.00%
Log In
Log In
Log In
Log In
Upgrade
Asia
5.44M
Log In
Log In
Log In
Log In
Upgrade
Asia Growth
23.78%
Log In
Log In
Log In
Log In
Upgrade
Australia
-
Log In
Log In
Log In
Log In
Upgrade
Australia Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade